Companies: Central Nervous System/Psychiatric/Schizophrenia

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs; Forums
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

Companies
Browse

Companies

Displaying 1..10 of 15 - per page Next page
Order by

Decision Resources Inc.

The worldwide leader in market research publications, advisory services and consulting More

Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals is a specialty pharmaceutical company specific expertise in developing differentiated products in collaboration with partners and for its own CNS product portfolio. More

NorthShore University HealthSystem Research Institute

NorthShore University HealthSystem Research Institute More

LAWSON Business Development

LAWSON HEALTH RESEARCH INSTITUTE is one of Canada's largest hospital-based research institutes. More

NPS Pharmaceuticals

NPS Pharmaceuticals is engaged in the discovery, development, and commercialization of therapeutic small molecules and recombinant proteins to treat bone, gastrointestinal, and CNS disorders More

GW Pharmaceuticals

GW Pharmaceuticals develops a range of medicines based on cannabinoids and other controlled drugs More

Desitin Arzneimittel GmbH

Success in CNS More

AstraZeneca

Is committed to building on success, and the continued in-licensing of products and technologies is an acknowledged strategic priority More

Jelfa Pharmaceutical Company

Production, distribution and marketing of solid, semi-solid and injectable preparations. More

Boehringer Ingelheim

We make your product a success - Boehringer Ingelheim provides highly attentive partnering that ensures enhanced value in all activities to fulfill your aspirations. More

Displaying 1..10 of 15 - per page Next page
Order by

Your selection

Therapeutic target: Central Nervous System del; Psychiatric del; Schizophrenia del

Browse By

Industry sector: Academic/Research; Animal health; Biotechnology; Diagnostic; Drug delivery; Drug discovery; Medical device; Non-profit org./Government; Pharmaceutical; Research tools; Service
Geographic location: Africa; Asia; Australia/New Zealand; Central America; Europe; Near & Far East; North America; South America

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us